SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Illumina (ILMN) Optics for Genomics
An SI Board Since July 2000
Posts SubjectMarks Bans Symbol
276 43 0 ILMN
Emcee:  Elmer Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51Illumina Reports Financial Results for First Quarter 2003 Wednesday April 23, 4mopgcw-4/27/2003
50The Wellcome Trust Sanger Institute Purchases Production-Scale SNP Genotyping Somopgcw-2/25/2003
49GS Update: ILMN reported a Q4 loss of $0.24/share excluding a litigation judgmemopgcw-2/6/2003
48Illumina Launches Human Genome RefSet Oligos for Spotted Gene Expression Microarmopgcw-2/5/2003
47Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2002 Bumopgcw-1/28/2003
46Genome Quebec Innovation Centre Purchases Production-Scale SNP Genotyping Solutimopgcw-1/9/2003
45Illumina Expands Portfolio of Standard SNP Genotyping Products and Services Compmopgcw-1/8/2003
44and so it begins... was just a matter of time (eom).mopgcw-12/5/2002
43SAN DIEGO--(BUSINESS WIRE)--Dec. 5, 2002--Illumina, Inc. (Nasdaq: ILMN - News) anigel bates-12/5/2002
42Illumina to Provide Oligonucleotides for Very Large-Scale Genomics Study At Coldmopgcw-12/3/2002
41From GS 10/30: ILMN reported a Q3 loss of $0.24/share excluding a litigation jumopgcw-10/30/2002
40Illumina Selected by the National Institutes of Health to Participate in the Intmopgcw-10/29/2002
39Illumina Reports Financial Results for Third Quarter 2002 Wednesday October 23, mopgcw-10/23/2002
38Illumina Appoints Susan Eddins to Head Worldwide Marketing Businesswire, Tumopgcw-10/4/2002
37Illumina Receives $9 Million from the National Institutes of Health for Large-Scmopgcw-10/1/2002
36Illumina To Conduct Large-Scale SNP Genotyping Services For GlaxoSmithKline Usemopgcw-9/19/2002
35Illumina Signs SNP Genotyping Agreement With the University of Cambridge, UK; Bemopgcw-8/27/2002
34From GS: ILMN reported a Q2 loss of $0.28/share excluding a 1 time litigation- mopgcw-7/28/2002
33Illumina Signs SNP Genotyping Agreement With the Wellcome Trust Sanger Institutemopgcw-7/25/2002
32Illumina Reports Financial Results for Second Quarter 2002 BusinessWire, Thursdamopgcw-7/19/2002
31Illumina Launches Integrated, High-Throughput SNP Genotyping System; Launch of Cmopgcw-7/9/2002
30Illumina Introduces SNP-Based Linkage Panel for High-Throughput Genetic Mapping mopgcw-6/13/2002
29Illumina Signs Genotyping Services Agreement With the University of North Carolimopgcw-5/31/2002
28Illumina Doubles Oligator DNA Synthesis Capacity and Launches $0.16 Per Base Olimopgcw-5/20/2002
27Illumina Receives $1.0 Million Phase 2 SBIR Grant From the National Institutes omopgcw-5/10/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News